Neuropathology of Cognitively Normal Elderly

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 11, 2003, Pages 1087-1095

  Knopman, David S ^a   Parisi, J E ^a   Salviati, A ^a   Floriach Robert, M ^a   Boeve, B F ^a   Ivnik, R J ^a   Smith, G E ^a   Dickson, D W ^b   Johnson, K A ^a   Petersen, L E ^a   McDonald, W C ^d   Braak, H ^c   Petersen, R C ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d Mayo Clinic ^*

Author keywords

Alzheimer; Cognition; Normal aging

Indexed keywords

TAU PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; ARGYROPHILIA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; LEWY BODY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0242693294     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.11.1087     Document Type: Article

References (44)

1. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
2. Crystal HA, Dickson DW, Sliwinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 1993;34:566-73
3. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases. Neurology 1988;38:359-64
4. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study. Ann Neurol 2002;51:567-77
5. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-75
6. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci 1968;7:331-56
7. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999;58:376-88
8. Hulette CM, Welsh-Bohmer KA, Murray MG, et al. Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 1998;57:1168-74
9. Morris JC, Storandt M, McKeel DW, Jr., et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-19
10. Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-68
11. Berg L, McKeel DW, Jr., Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998;55:326-35
12. Smith GE, Bohac DL, Waring SC, et al. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects. Neurology 1998;50:355-62
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
14. Tangalos EG, Smith GE, Ivnik RJ, et al. The Mini-Mental State Examination in general medical practice: Clinical utility and acceptance. Mayo Clin Proc 1996;71:829-37
15. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-91
16. Mattis S. Mental status examination for organic mental syndromes in the elderly patient, in geriatric psychiatry. A handbook for psychiatrists and primary care physicians. In: Bellak L, Karasu TE, eds. New York: Grune and Stratton, 1976:77-101
17. Lucas JA, Ivnik RJ, Smith GE, et al. Normative data for the Mattis Dementia Rating Scale. J Clin Exp Neuropsychol 1998;20:536-47
18. Smith GE, Ivnik RJ, Malec JF, et al. Psychometric Properties of the Mattis Dementia Rating Scale. Assessment 1994;1:123-32
19. Wechsler DA. Wechsler Memory Scale-Revised. New York: Psychological Corporation, 1987
20. Petersen RC, Kokmen E, Tangalos E, Ivnik RJ, Kurland LT. Mayo Clinic Alzheimer's Disease Patient Registry. Aging (Milano) 1990;2:408-15
21. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-78
22. Duyckaerts C, Bennecib M, Grignon Y, et al. Modeling the relation between neurofibrillary tangles and intellectual status. Neurobiol Aging 1997:18:267-73
23. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992;13:179-89
24. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-59
25. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988:51:745-52
26. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-24
27. Braak H, Braak E. Argyrophilic grain disease: Frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm 1998;105:801-19
28. Togo T, Sahara N, Yen SH, et al. Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol 2002;61:547-56
29. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997:56:1095-97
30. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
31. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997;18:351-57
32. Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E, The incidence of Alzheimer's disease does not vary by gender in Rochester, Minnesota. Arch Neurol 2002;59:1589-93
33. Tierney MC, Szalai JP, Snow WG, Fisher RH. The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. Arch Neurol 1996;53:423-27
34. Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994;44:1427-32
35. Jacobs DM, Sano M, Dooneief G, et al. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995;45:957-62
36. Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-24
37. Howieson DB, Dame A, Camicioli R, et al. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 1997;45:584-89
38. Elias MF, Beiser A, Wolf PA, et al. The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham cohort. Arch Neurol 2000;57:808-13
39. Nagy Z, Esiri MM, Jobst KA, et al. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: Correlations using three sets of neuropathological criteria. Dementia 1995;6:21-31
40. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-39
41. Sparks DL, Hunsaker JC 3rd, Scheff SW, et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990;11:601-7
42. Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 1997;56:165-70
43. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia aging study participants. Ann N Y Acad Sci 2002;977:9-23
44. Knopman D, Parisi JE, Rocca WA, et al. Vascular dementia in a community-based autopsy study. Arch Neurol 2003;60:569-76